Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001140361-25-040534·ADC Therapeutics SA
Schedule 13G ownership disclosure
ADC THERAPEUTICS SA
Common Shares · CUSIP: H0036K147
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Oaktree Fund Administration, LLC
Shares: 4,673,441 · Class: 4.14%
- Oaktree Capital Holdings, LLC
Shares: 4,673,441 · Class: 4.14%
- Oaktree Capital Group Holdings GP, LLC
Shares: 4,673,441 · Class: 4.14%
- Brookfield Asset Management ULC
Shares: 0 · Class: 0%
- Brookfield Corporation
Shares: 0 · Class: 0%
- Brookfield Asset Management, Ltd.
Shares: 0 · Class: 0%
- BAM Partners Trust
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-040534
- Form type
- SCHEDULE 13G/A
- Filer
- ADC Therapeutics SA
- CIK
- CIK 1771910
- Filed
- Nov 05, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership